Literature DB >> 33639874

The 5-year overall survival of cervical cancer in stage IIIC-r was little different to stage I and II: a retrospective analysis from a single center.

E Yang1, Shuying Huang1, Xuting Ran1, Yue Huang1, Zhengyu Li2,3.   

Abstract

BACKGROUND: The 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline for cervical cancer includes stage IIIC recognized by preoperative radiology (IIIC-r) to state there are lymph nodes metastases (LNM) identified by imaging tools. We aim to explore the reasonability and limitations of stage IIIC-r and try to explore the potential reasons.
METHODS: Electronic medical records were used to identify patients with cervical cancer. According to the new staging guidelines, patients were reclassified and assigned into five cohorts: stage I, stage II, stage IIIC-r, LNM confirmed by pathology (IIIC-p) and LNM detected by radiology and confirmed by pathology (IIIC r + p). Five-year overall survivals were estimated for each cohort. The diagnosis accuracy of computed tomography (CT), magnetic resonance imaging (MRI) and diameter of detected lymph nodes were also evaluated.
RESULTS: A total of 619 patients were identified. The mean follow-up months were 65 months (95% CI 64.43-65.77) for all patients. By comparison, the 5-year overall survival rates were not statistically different (p = 0.21) among stage IIIC-r, stage I and stage II. While, the rates were both statistical different (p<0.001) among stage IIIC-p, IIIC r + p and stage I and stage II. The sensitivities of CT and MRI in detecting LNM preoperatively were 51.2 and 48.8%. The mean maximum diameter of pelvic lymph nodes detected by CT cohort was 1.2 cm in IIIC-r cohort, and was 1.3 cm in IIIC r + p cohort. While, the mean maximum diameter of pelvic lymph nodes detected by MRI was 1.2 cm in IIIC-r cohort, and was 1.48 cm in IIIC r + p cohort. When the diagnosis efficacy of the diameter of pelvic lymph nodes in detecting LNM were evaluated, the area under the receiver operating characteristic curve (ROC curve) was 0.58 (p = 0.05).
CONCLUSIONS: It seems that the FIGO 2018 staging guideline for cervical cancer is likely to has certain limitations for the classification of those with LNM. CT or MRI, however, has limitations on detecting LNM. It would be better to use more accurate imaging tools to identify LNM in the clinical practices.

Entities:  

Keywords:  Cervical cancer; Lymph nodes metastases; Overall survival; The revised 2018 International Federation of Gynecology and Obstetrics (FIGO) staging guideline

Mesh:

Year:  2021        PMID: 33639874      PMCID: PMC7912513          DOI: 10.1186/s12885-021-07890-w

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  27 in total

1.  Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.

Authors:  Hyun Hoon Chung; Keon Wook Kang; Jeong Yeon Cho; Jae Weon Kim; Noh-Hyun Park; Yong-Sang Song; Seung Hyup Kim; June-Key Chung; Soon-Beom Kang
Journal:  Am J Obstet Gynecol       Date:  2010-05-01       Impact factor: 8.661

2.  Differentiation of metastatic from non-metastatic lymph nodes in patients with uterine cervical cancer using diffusion-weighted imaging.

Authors:  Ying Liu; Haidong Liu; Xu Bai; Zhaoxiang Ye; Haoran Sun; Renju Bai; Dehua Wang
Journal:  Gynecol Oncol       Date:  2011-04-15       Impact factor: 5.482

3.  Diagnostic performance of diffusion-weighted MRI for detection of pelvic metastatic lymph nodes in patients with cervical cancer: a systematic review and meta-analysis.

Authors:  G Shen; H Zhou; Z Jia; H Deng
Journal:  Br J Radiol       Date:  2015-05-29       Impact factor: 3.039

Review 4.  A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies.

Authors:  Bin Liu; Sujuan Gao; Shuofeng Li
Journal:  Gynecol Obstet Invest       Date:  2017-02-10       Impact factor: 2.031

5.  Prognostic Performance of the 2018 International Federation of Gynecology and Obstetrics Cervical Cancer Staging Guidelines.

Authors:  Jason D Wright; Koji Matsuo; Yongmei Huang; Ana I Tergas; June Y Hou; Fady Khoury-Collado; Caryn M St Clair; Cande V Ananth; Alfred I Neugut; Dawn L Hershman
Journal:  Obstet Gynecol       Date:  2019-07       Impact factor: 7.661

Review 6.  Is lymph vascular space involvement an independent prognostic factor in early cervical cancer?

Authors:  William T Creasman; Matthew F Kohler
Journal:  Gynecol Oncol       Date:  2004-02       Impact factor: 5.482

7.  Validation of the 2018 FIGO cervical cancer staging system.

Authors:  Koji Matsuo; Hiroko Machida; Rachel S Mandelbaum; Ikuo Konishi; Mikio Mikami
Journal:  Gynecol Oncol       Date:  2018-10-30       Impact factor: 5.482

Review 8.  Computed tomography and magnetic resonance imaging in staging of uterine cervical carcinoma: a systematic review.

Authors:  Shandra Bipat; Afina S Glas; Jacobus van der Velden; Aeilko H Zwinderman; Patrick M M Bossuyt; Jaap Stoker
Journal:  Gynecol Oncol       Date:  2003-10       Impact factor: 5.482

9.  Intraoperative multispectral fluorescence imaging for the detection of the sentinel lymph node in cervical cancer: a novel concept.

Authors:  Lucia M A Crane; George Themelis; Rick G Pleijhuis; Niels J Harlaar; Athanasios Sarantopoulos; Henriette J G Arts; Ate G J van der Zee; Vasilis Ntziachristos; Ntziachristos Vasilis; Gooitzen M van Dam
Journal:  Mol Imaging Biol       Date:  2011-10       Impact factor: 3.488

10.  Sentinel lymph node biopsy in early stage cervical cancer: A meta-analysis.

Authors:  Xinyue Zhang; Bingting Bao; Sixue Wang; Mingyu Yi; Li Jiang; Xiaoling Fang
Journal:  Cancer Med       Date:  2020-12-13       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.